Strengthening an Already Vibrant Sector: USAID Support to Jordan's Pharmaceutical Industry
JCP's support to Jordan's pharmaceutical industry extends to the private sector as well as to the Jordan Food and Drug Administration (JFDA). On April 4, 2017, USAID signed a partnership agreement with the JFDA to expedite and streamline the drug registration process to reduce the time to market for Jordanian medicines, including automation of the drug registration process and capacity-building of JFDA staff. Speaking at the signing ceremony, USAID Mission Director Dr. Jim Barnhart noted that “pharmaceutical companies sell 80 percent of their production to more than 60 countries worldwide, representing nine percent of Jordan’s total exports.”
JCP’s work with the JFDA is ultimately about benefitting the wider Jordanian economy, but we also work directly with the pharmaceutical sector's leading business association, the Jordanian Association of Pharmaceutical Manufacturers (JAPM), to institute an electronic drug registration and application system aimed at reducing the time to market for these products -- thus making the entire sector more competitive. This system will interact seamlessly with a parallel one at the JFDA, which was also supported by JCP. In fact, the JFDA has already successfully rolled out a live version of the new electronic Common Technical Document (eCTD) review tool and initiated the pilot testing of the system with five drug dossiers followed by a second pilot phase ahead of the system's full public launch, scheduled for March 2019.
Check out this video to learn more about USAID's work with the Jordanian pharmaceutical sector: